173 related articles for article (PubMed ID: 27310997)
1. Can S-1 replace fluorouracil for advanced gastric cancer? A PRISMA-compliant systematic review and meta-analysis.
Chen XD; He FQ; Chen M; Tang LC; Tang XL
Medicine (Baltimore); 2016 Jun; 95(24):e3916. PubMed ID: 27310997
[TBL] [Abstract][Full Text] [Related]
2. A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric Cancer.
Wu FL; Lu DC; Ying YP; Huang JJ; Zhou AM; Jiang DK; Chen MW; Yang X; Zhou J; Huang HQ; Zeng HY
Medicine (Baltimore); 2015 Apr; 94(16):e652. PubMed ID: 25906091
[TBL] [Abstract][Full Text] [Related]
3. S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.
He MM; Wu WJ; Wang F; Wang ZQ; Zhang DS; Luo HY; Qiu MZ; Wang FH; Ren C; Zeng ZL; Xu RH
PLoS One; 2013; 8(12):e82798. PubMed ID: 24349363
[TBL] [Abstract][Full Text] [Related]
4. S-1-based therapy versus 5-FU-based therapy in advanced gastric cancer: a meta-analysis.
Huang J; Cao Y; Wu L; Liao C; He Y; Gao F
Med Oncol; 2011 Dec; 28(4):1004-11. PubMed ID: 20552300
[TBL] [Abstract][Full Text] [Related]
5. Survival benefit from S-1 as compared to Fluorouracil in Asian patients with advanced gastrointestinal cancer: a meta-analysis.
Cao C; Zhang X; Kuang M; Gu D; He M; Chen J; Tang C
Cancer Sci; 2014 Aug; 105(8):1008-14. PubMed ID: 24974863
[TBL] [Abstract][Full Text] [Related]
6. S-1-based vs non-S-1-based chemotherapy in advanced gastric cancer: a meta-analysis.
Yang J; Zhou Y; Min K; Yao Q; Xu CN
World J Gastroenterol; 2014 Sep; 20(33):11886-93. PubMed ID: 25206296
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis.
Ter Veer E; Mohammad NH; Lodder P; Ngai LL; Samaan M; van Oijen MG; van Laarhoven HW
Gastric Cancer; 2016 Jul; 19(3):696-712. PubMed ID: 26754295
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Platinum/S-1 and Platinum/5-Fluorouracil as First-Line Chemotherapy for Advanced Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis Based on Randomized Controlled Trials.
Luo D; Wang L; Chen X; Xiong Y; Yi F; Ding J; Ding H; Wei Y; Zhang W
Chemotherapy; 2020; 65(1-2):11-20. PubMed ID: 32535588
[TBL] [Abstract][Full Text] [Related]
9. S-1-based versus 5-FU-based chemotherapy as first-line treatment in advanced gastric cancer: a meta-analysis of randomized controlled trials.
Li DH; Pan ZK; Ye F; An HX; Wu JX
Tumour Biol; 2014 Aug; 35(8):8201-8. PubMed ID: 24850178
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and toxicity of paclitaxel plus S-1 compared with paclitaxel plus 5-FU for advanced gastric cancer: a PRISMA systematic review and meta-analysis of randomized controlled trials.
Liu H; Chen X; Sun J; Gao P; Song Y; Zhang N; Lu X; Xu H; Wang Z
Medicine (Baltimore); 2014 Nov; 93(25):e164. PubMed ID: 25437030
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine for the treatment for advanced gastric cancer: efficacy, safety and ethnicity.
Ma Y; Tang L; Wang HX; Xu YC; Ma Y; Zhang FC
J Clin Pharm Ther; 2012 Jun; 37(3):266-75. PubMed ID: 21950464
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of capecitabine-based versus S-1-based chemotherapy for metastatic or recurrent gastric cancer: a systematic review and meta-analysis of clinical randomized trials.
Feng Z; Yan P; Hou X; Feng J; He X; Yang K
Ann Palliat Med; 2020 May; 9(3):883-894. PubMed ID: 32389017
[TBL] [Abstract][Full Text] [Related]
13. S-1-based combination therapy vs S-1 monotherapy in advanced gastric cancer: a meta-analysis.
Liu GF; Tang D; Li P; Wang S; Xu YX; Long AH; Zhou NL; Zhang LL; Chen J; Xiang XX
World J Gastroenterol; 2014 Jan; 20(1):310-8. PubMed ID: 24415887
[TBL] [Abstract][Full Text] [Related]
14. S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysis.
Bian NN; Wang YH; Min GT
Int J Surg; 2019 Feb; 62():34-43. PubMed ID: 30641155
[TBL] [Abstract][Full Text] [Related]
15. S-1 (Teysuno®): a review of its use in advanced gastric cancer in non-Asian populations.
Sanford M
Drugs; 2013 Jun; 73(8):845-55. PubMed ID: 23719766
[TBL] [Abstract][Full Text] [Related]
16. Kanglaite injection plus fluorouracil-based chemotherapy on the reduction of adverse effects and improvement of clinical effectiveness in patients with advanced malignant tumors of the digestive tract: A meta-analysis of 20 RCTs following the PRISMA guidelines.
Song Q; Zhang J; Wu Q; Li G; Leung EL
Medicine (Baltimore); 2020 Apr; 99(17):e19480. PubMed ID: 32332600
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
18. S-1 plus cisplatin with concurrent radiotherapy for stage III non-small cell lung cancer: A meta-analysis (PRISMA) of randomized control trials.
Qie S; Li Y; Shi HY; Yuan L; Zhang X
Medicine (Baltimore); 2018 Dec; 97(50):e13441. PubMed ID: 30557998
[TBL] [Abstract][Full Text] [Related]
19. S-1-based therapy versus S-1 monotherapy in advanced gastric cancer: a meta-analysis.
Wu JR; Tang WZ; Chen X; Xie YT; Chen SY; Peng QL; Xie L; Deng Y; Li TJ; He Y; Wang J; Li S; Qin X
Tumour Biol; 2014 Apr; 35(4):3283-93. PubMed ID: 24390661
[TBL] [Abstract][Full Text] [Related]
20. Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials.
Bin Q; Li J; Liao C; Cao Y; Gao F
Colorectal Dis; 2011 Aug; 13(8):837-45. PubMed ID: 20050863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]